IMMUNOTHERAPY OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE) - DIFFERENTIAL EFFECT OF ANTI-IL-2 RECEPTOR ANTIBODY THERAPY ON ACTIVELY INDUCED AND T-LINE MEDIATED EAE OF THE LEWIS RAT

被引:29
作者
ENGELHARDT, B
DIAMANTSTEIN, T
WEKERLE, H
机构
[1] MAX PLANCK GESELL,KLIN FORSCH GPP MULTIPLE SKLEROSE,POB 6120,D-8700 WURZBURG,FED REP GER
[2] FREE UNIV BERLIN,INST IMMUNOL,D-1000 BERLIN 33,FED REP GER
关键词
D O I
10.1016/0896-8411(89)90108-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:61 / 73
页数:13
相关论文
共 34 条
[11]   THE INTERLEUKIN-2 RECEPTOR, ITS PHYSIOLOGY AND A NEW APPROACH TO A SELECTIVE IMMUNOSUPPRESSIVE THERAPY BY ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODIES [J].
DIAMANTSTEIN, T ;
OSAWA, H .
IMMUNOLOGICAL REVIEWS, 1986, 92 :5-27
[12]   ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODIES SPARE PHENOTYPICALLY DISTINCT T-SUPPRESSOR CELLS INVIVO AND EXERT SYNERGISTIC BIOLOGICAL EFFECTS [J].
DISTEFANO, R ;
MOUZAKI, A ;
ARANEDA, D ;
DIAMANTSTEIN, T ;
TILNEY, NL ;
KUPIECWEGLINSKI, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (06) :1981-1986
[13]  
Eylar E H, 1974, Methods Enzymol, V32, P323
[14]   T-CELL ACTIVATION IN HEALTH AND DISEASE [J].
FELDMANN, M .
IMMUNOLOGY TODAY, 1988, 9 (05) :121-124
[15]  
GILMAN SC, 1982, J IMMUNOL, V129, P1012
[16]   CURING BB RATS OF FRESHLY MANIFESTED DIABETES BY SHORT-TERM TREATMENT WITH A COMBINATION OF A MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY AND A SUBTHERAPEUTIC DOSE OF CYCLOSPORINE-A [J].
HAHN, HJ ;
LUCKE, S ;
KLOTING, I ;
VOLK, HD ;
BAEHR, RV ;
DIAMANTSTEIN, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (07) :1075-1078
[17]  
KELLEY VE, 1988, J IMMUNOL, V140, P59
[18]  
KLINKERT WEF, 1987, J IMMUNOL, V139, P1030
[19]  
KUPIECWEGLINSKI JW, 1988, TRANSPLANT P, V20, P272
[20]  
KUPIECWEGLINSKI JW, 1987, TRANSPLANT P, V19, P591